Ángel Ramírez-Fernández

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Acute Lymphoblastic Leukemia

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Mesenchymal Stem Cells

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas, Paola A Romencín, Alba Martínez-Moreno, Marina Gómez-Rosel, Belén Blanco, Anaïs Jiménez-Reinoso, Andrea Mayado, Alba Pérez-Pons, Oscar Aguilar-Sopeña, Ángel Ramírez-Fernández, Alejandro Segura-Tudela, Lorena Perez-Amill, Antonio Tapia-Galisteo, Carmen Domínguez-Alonso, Laura Rubio-Pérez, Maria Jara, Francisco Solé, Oana Hangiu, Laura Almagro, Ángela Albitre, Petronila Penela, Laura Sanz, Eduardo Anguita, Antonio Valeri, Almudena García-Ortiz, Paula Rio, Manel Juan, Joaquín Martínez-López, Pedro Roda-Navarro, Beatriz Martin-Antonio, Alberto Orfao, Pablo Menéndez, Clara Bueno, Luis Alvarez-Vallina
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo. Science translational medicine 16 (734) (2024)
Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas, Paola A Romencín, Alba Martínez-Moreno, Marina Gómez-Rosel, Belén Blanco, Anaïs Jiménez-Reinoso, Andrea Mayado, Alba Pérez-Pons, Oscar Aguilar-Sopeña, Ángel Ramírez-Fernández, Alejandro Segura-Tudela, Lorena Perez-Amill, Antonio Tapia-Galisteo, Carmen Domínguez-Alonso, Laura Rubio-Pérez, Maria Jara, Francisco Solé, Oana Hangiu, Laura Almagro, Ángela Albitre, Petronila Penela, Laura Sanz, Eduardo Anguita, Antonio Valeri, Almudena García-Ortiz, Paula Rio, Manel Juan, Joaquín Martínez-López, Pedro Roda-Navarro, Beatriz Martin-Antonio, Alberto Orfao, Pablo Menéndez, Clara Bueno, Luis Alvarez-Vallina
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo. Science translational medicine 16 (734) (2024)
Anaïs Jiménez-Reinoso, Magdalena Molero, Cristina Cirauqui, Belén Blanco, Eva Maria Garrido-Martin, Daniel Nehme-Álvarez, Carmen Domínguez-Alonso, Ángel Ramírez-Fernández, Laura Díez-Alonso, Ángel Nuñez-Buiza, África Gónzalez-Murillo, Raquel Tobes, Eduardo Pareja, Manuel Ramírez, José Luis Rodriguez-Peralto, Irene Ferrer, Jon Zugazagoitia, Luis G Paz-Ares, Luis Alvarez-Vallina
CD4 + tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts. Oncoimmunology 13 (1) (2024)
Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas, Paola A Romencín, Alba Martínez-Moreno, Marina Gómez-Rosel, Belén Blanco, Anaïs Jiménez-Reinoso, Andrea Mayado, Alba Pérez-Pons, Oscar Aguilar-Sopeña, Ángel Ramírez-Fernández, Alejandro Segura-Tudela, Lorena Perez-Amill, Antonio Tapia-Galisteo, Carmen Domínguez-Alonso, Laura Rubio-Pérez, Maria Jara, Francisco Solé, Oana Hangiu, Laura Almagro, Ángela Albitre, Petronila Penela, Laura Sanz, Eduardo Anguita, Antonio Valeri, Almudena García-Ortiz, Paula Rio, Manel Juan, Joaquín Martínez-López, Pedro Roda-Navarro, Beatriz Martin-Antonio, Alberto Orfao, Pablo Menéndez, Clara Bueno, Luis Alvarez-Vallina
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo. Science translational medicine 16 (734) (2024)
Anaïs Jiménez-Reinoso, Magdalena Molero, Cristina Cirauqui, Belén Blanco, Eva Maria Garrido-Martin, Daniel Nehme-Álvarez, Carmen Domínguez-Alonso, Ángel Ramírez-Fernández, Laura Díez-Alonso, Ángel Nuñez-Buiza, África Gónzalez-Murillo, Raquel Tobes, Eduardo Pareja, Manuel Ramírez, José Luis Rodriguez-Peralto, Irene Ferrer, Jon Zugazagoitia, Luis G Paz-Ares, Luis Alvarez-Vallina
CD4 + tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts. Oncoimmunology 13 (1) (2024)
Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean Lykke Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutierrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J Blanco, Cruz Santos, José Luis Rodriguez-Peralto, Laura Sanz, Luis Alvarez-Vallina
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. Oncoimmunology 12 (1) (2023)
Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean Lykke Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutierrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J Blanco, Cruz Santos, José Luis Rodriguez-Peralto, Laura Sanz, Luis Alvarez-Vallina
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. Oncoimmunology 12 (1) (2023)
Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean Lykke Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutierrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J Blanco, Cruz Santos, José Luis Rodriguez-Peralto, Laura Sanz, Luis Alvarez-Vallina
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. Oncoimmunology 12 (1) (2023)
Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean Lykke Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutierrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J Blanco, Cruz Santos, José Luis Rodriguez-Peralto, Laura Sanz, Luis Alvarez-Vallina
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. Oncoimmunology 12 (1) (2023)
Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean Lykke Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutierrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J Blanco, Cruz Santos, José Luis Rodriguez-Peralto, Laura Sanz, Luis Alvarez-Vallina
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. Oncoimmunology 12 (1) (2023)
Ángel Ramírez-Fernández, Oscar Aguilar-Sopeña, Laura Díez-Alonso, Alejandro Segura-Tudela, Carmen Domínguez-Alonso, Pedro Roda-Navarro, Luis Alvarez-Vallina, Belén Blanco
Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies. Oncoimmunology 11 (1) (2022)